341 related articles for article (PubMed ID: 27613057)
1. Global MS-Based Proteomics Drug Profiling.
Carvalho AS; Matthiesen R
Methods Mol Biol; 2016; 1449():469-79. PubMed ID: 27613057
[TBL] [Abstract][Full Text] [Related]
2. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
Manes NP; Nita-Lazar A
J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics.
Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R
Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226
[TBL] [Abstract][Full Text] [Related]
5. Bottom up proteomics data analysis strategies to explore protein modifications and genomic variants.
Carvalho AS; Penque D; Matthiesen R
Proteomics; 2015 Jun; 15(11):1789-92. PubMed ID: 25684358
[TBL] [Abstract][Full Text] [Related]
6. The contribution of mass spectrometry-based proteomics to understanding epigenetics.
Noberini R; Sigismondo G; Bonaldi T
Epigenomics; 2016 Mar; 8(3):429-45. PubMed ID: 26606673
[TBL] [Abstract][Full Text] [Related]
7. The emerging field of chemo- and pharmacoproteomics.
Hess S
Proteomics Clin Appl; 2013 Jan; 7(1-2):171-80. PubMed ID: 23184895
[TBL] [Abstract][Full Text] [Related]
8. Integrating transcriptome and proteome profiling: Strategies and applications.
Kumar D; Bansal G; Narang A; Basak T; Abbas T; Dash D
Proteomics; 2016 Oct; 16(19):2533-2544. PubMed ID: 27343053
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A; Ralhan R; DeSouza LV; Siu KW
Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
[TBL] [Abstract][Full Text] [Related]
10. Obtaining Complete Human Proteomes.
Martinez-Val A; Guzmán UH; Olsen JV
Annu Rev Genomics Hum Genet; 2022 Aug; 23():99-121. PubMed ID: 35440146
[TBL] [Abstract][Full Text] [Related]
11. Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.
Murray HC; Dun MD; Verrills NM
Expert Opin Drug Discov; 2017 May; 12(5):431-447. PubMed ID: 28286965
[TBL] [Abstract][Full Text] [Related]
12. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
Savino R; Terracciano R
Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
[TBL] [Abstract][Full Text] [Related]
13. Pathway proteomics and chemical proteomics team up in drug discovery.
Hopf C; Bantscheff M; Drewes G
Neurodegener Dis; 2007; 4(2-3):270-80. PubMed ID: 17596721
[TBL] [Abstract][Full Text] [Related]
14. Global proteomics profiling improves drug sensitivity prediction: results from a multi-omics, pan-cancer modeling approach.
Ali M; Khan SA; Wennerberg K; Aittokallio T
Bioinformatics; 2018 Apr; 34(8):1353-1362. PubMed ID: 29186355
[TBL] [Abstract][Full Text] [Related]
15. Proteomics approaches for myeloid leukemia drug discovery.
Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
[TBL] [Abstract][Full Text] [Related]
16. Application of LC/MS to proteomics studies: current status and future prospects.
Chen G; Pramanik BN
Drug Discov Today; 2009 May; 14(9-10):465-71. PubMed ID: 19429505
[TBL] [Abstract][Full Text] [Related]
17. Dissecting intercellular signaling with mass spectrometry-based proteomics.
Swietlik JJ; Sinha A; Meissner F
Curr Opin Cell Biol; 2020 Apr; 63():20-30. PubMed ID: 31927463
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in proteomics: implications for the study of cardiac hypertrophy and failure.
Faber MJ; Agnetti G; Bezstarosti K; Lankhuizen IM; Dalinghaus M; Guarnieri C; Caldarera CM; Helbing WA; Lamers JM
Cell Biochem Biophys; 2006; 44(1):11-29. PubMed ID: 16456231
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry for proteomics-based investigation.
Woods AG; Sokolowska I; Ngounou Wetie AG; Wormwood K; Aslebagh R; Patel S; Darie CC
Adv Exp Med Biol; 2014; 806():1-32. PubMed ID: 24952176
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
